PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable device.

Altum Sequencing has developed a tool that uses a simple blood sample for monitoring treatment response in individuals with ...

The European Commission (EC) will restrict Chinese firms from EU government purchases of medical devices exceeding €5m ($5.7m ...

The US Food and Drug Administration (FDA) has approved Neuspera Medical’s integrated sacral neuromodulation (iSNM) system for ...

GE HealthCare has announced the renewal of its research partnership with Stanford Medicine, US, focusing on the PET/CT ...

Invivoscribe's subsidiary, LabPMM, has secured New York State (NYS) approval for the NPM1 MRD Assay to combat acute myeloid ...

Penumbra stands to maintain its market lead and possibly increase its market share as the purchasing of the Ruby XL system ...

Qiagen, Incyte have announced a master collaboration agreement to create a diagnostic panel to aid in the treatment of ...

GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform ...

Penumbra has completed subject enrolment in the multi-centre, randomised controlled trial, STORM-PE, for pulmonary embolism ...

Beset by seemingly endless responsibilities, within the UK's NHS and other healthcare systems globally, burnout among GPs is ...

InspireMD’s CGuard Prime Embolic Prevention System (EPS) has secured CE Mark approval under the European MDR for stroke ...